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Replication of H9 influenza viruses 
in the human ex vivo respiratory 
tract, and the influence of 
neuraminidase on virus release
Renee W. Y. Chan1,5, Louisa L. Y. Chan1, Chris K. P. Mok2, Jimmy Lai2, Kin P. Tao1,5, Adebimpe 
Obadan3, Michael C. W. Chan1, Daniel R. Perez  3, J. S. Malik Peiris1 & John M. Nicholls4
H9N2 viruses are the most widespread influenza viruses in poultry in Asia. We evaluated the 
infection and tropism of human and avian H9 influenza virus in the human respiratory tract using 
ex vivo respiratory organ culture. H9 viruses infected the upper and lower respiratory tract and the 
majority of H9 viruses had a decreased ability to release virus from the bronchus rather than the lung. 
This may be attributed to a weak neuraminidase (NA) cleavage of carbon-6-linked sialic acid (Sia) 
rather than carbon-3-linked Sia. The modified cleavage of N-acetlylneuraminic acid (Neu5Ac) and 
N-glycolylneuraminic acid (Neu5Gc) by NA in H9 virus replication was observed by reverse genetics, and 
recombinant H9N2 viruses with amino acids (38KQ) deleted in the NA stalk, and changing the amino 
acid at position 431 from Proline-to-Lysine. Using recombinant H9 viruses previously evaluated in the 
ferret, we found that viruses which replicated well in the ferret did not replicate to the same extent in 
the human ex vivo cultures. The existing risk assessment models for H9N2 viruses in ferrets may not 
always have a strong correlation with the replication in the human upper respiratory tract. The inclusion 
of the human ex vivo cultures would further strengthen the future risk-assessment strategies.
Most influenza viruses are widely established in the waterfowl population. While much attention has been given 
to the H5N1 and H7N9 subtypes, because of their disease severity in humans, another subtype, H9N2, has widely 
circulated in poultry in many regions of the world. H9N2 was first detected in turkeys in 1966, shorebirds in 
1988, and then in ducks and chickens1, 2. It is now the most widespread and prevalent influenza virus in Asia. 
The government of Hong Kong Special Administrative Region implemented interventions starting from 2001 to 
control this infection, by executing a mandatory monthly rest day, live quail sale ban, and in the subsequent years 
a biweekly rest day in the wet markets. Prior to these interventions in live bird market trading, the H9N2 virus 
isolation rate in Hong Kong’s live poultry markets was around 5% of all birds tested increasing to almost 20% in 
game-birds such as quail3. These isolation rates are presumably similar in the greater China region in which H9N2 
is regarded as the most prevalent subtype of influenza in chickens (reviewed in ref. 4), where market interventions 
applied in Hong Kong have not been used. Phylogenetic analysis has shown that the three main lineages (Korean, 
G1 and Chicken/Beijing/1/94-like) of H9N2 viruses have developed from Ck/Bei and reassorted, with other H9 
strains1.
Even though H9N2 infection is mainly confined to poultry, H9N2 viruses have been detected repeatedly in 
swine in China5, 6. Laboratory confirmed cases of H9N2 infection in humans have been reported in 19997, 8, 20059, 
200810 and 201311 and it appears that immunocompromised individuals may be more susceptible to H9N2 infec-
tion10. The early human H9N2 cases were identified in Hong Kong from 1999 to 20039, 12 (reviewed in ref. 10), in 
children who presented with a mild influenza-like illness. Later cases identified in Hong Kong10 and Mainland 
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China11 occurred in adults. These isolated cases might only reflect the tip of the iceberg, as the high prevalence 
of anti-H9 antibodies among poultry workers in China13, Vietnam14, and Iran15 raises the possibility that mild or 
asymptomatic infection of H9N2 in human could be common.
Serological surveillance in China has shown that 1.4% of the population have antibodies to H9N2 as 
determined by haemagglutination inhibition and virus neutralization16. Among pig farm workers in the 
Southern China, 1.4% of staff were seropositive with 4% of pigs showing seroconversion17. A more detailed 
sero-epidemiological study from Thailand found that 4.7% of the population had elevated antibody titres 
to H9N218. These previous publications thus indicate that H9 infections in human could be common in the 
Asian-Pacific region.
Recent publications have sought to risk assess the pandemic potential of H9N2 viruses using in vitro cell 
culture and laboratory animal infection systems19. For many years the ferret has been used as a surrogate human 
model for influenza studies reviewed in (Belser et al.)20 and there has been limited data on replication competence 
in the ex vivo respiratory organ culture of ferret with good validation. We sought to explore the tissue tropism of 
the wild type H9 viruses isolated from poultry and humans in the ex vivo cultures of the human bronchus and 
lung and to investigate if there was any unique viral genomic signature which would determine successful rep-
lication in the human airways and which would act as a predictor, or correlate of infection in humans. We also 
sought to explore the how previously characterized changes in the internal viral proteins would affect replication 
as well comparing the N1 against the N2 for replication competence. As changes in amino acid at position 190 in 
haemagglutinin (HA) have been proposed to affect receptor binding21 and serial passage in animal models has 
also been demonstrated to affect replication22. We produced a recombinant virus with this change with 464419/
H9N2 as the backbone (listed in Table 1 and Supplementary materials, Table S1) in our assessment in ex vivo 
human respiratory tissue cultures.
Results
Human H9N2 influenza virus replication in the human bronchus and lung organ cultures. We 
have determined the infectivity and viral replication competence of human H9N2 influenza viruses A/Hong 
Kong/1073/1999(1073), A/Hong Kong/2108/2003 (2108), A/Hong Kong/226995/2008 (226995) and A/Hong 
Kong/464419/2009 (464419) (Table 1) in ex vivo cultures of human bronchus and lung. Immunohistochemistry 
studies indicated that there was infection of the bronchial epithelium (Fig. 1A–E), and the lung (Fig. 1G–K). The 
lung ex vivo cultures infected with human H9N2 viruses, 1073 and 464419 showed a greater extent of infection 
than other two H9N2 strains, 2108 and 226995 (Fig. 1G and J). Virus replication kinetic data indicated there was 
no significant increase in the viral titer in the bronchus with 1073, 2108 and D190E, over the infection time course 
Strain name Subtype Abbreviation
A/Shanghai/2/2013 H7N9 Sh2 WT
A/Quail/Hong Kong/G1/1997 H9N2 G1 WT
A/Duck/Hong Kong/Y280/1997 H9N2 Y280 WT
A/Duck/Shantou/2030/2001 H9N1 Dk/2030 WT
A/Chicken/Hong Kong/SSP117W/2009 H9N2 Ck/SSP WT
A/Chicken/Hong Kong/YU341/2008 H9N2 Ck/YU341 WT
A/Chicken/Hong Kong/NT449/2007 H9N2 Ck/NT449 WT
A/Hong Kong/1073/1999 H9N2 1073 WT
A/Hong Kong/2108/2003 H9N2 2108 WT
A/Hong Kong/226995/2008 H9N2 226995 WT
A/Hong Kong/464419/2009 H9N2 464419 WT
A/Hong Kong/464419/2009 HA-D190E H9N2 D190E RG
A/California/04/2009 H1N1pdm Ca04 WT
G1 HANA: 6 × A/California/04/2009 internal genes H9N2 rgH9N2 RG
G1 HA: 7 × A/California/04/2009 genes H9N1 rgH9N1 RG
A/guinea fowl/Hong Kong/WF10/1999 H9N2 WF10 WT
A/Memphis/14/1998 H3N2 M98 WT
A/Netherlands/602/2009 H1N1pdm / WT
WF10 HA: 7 × A/Netherlands/602/2009 genes H9N1 1WF10 RG
WF10 HANA: 6 × A/Netherlands/602/2009 internal genes H9N2 2WF10 RG
WF10 HANA: 6 × M98 internal genes H9N2 2WF10:6M98 RG
A/Ferret/Maryland/P10_UMD/2008 H9N2 P10 AD
P10 HA: 7 × A/Netherlands/602/2009 genes H9N1 1P10 RG
P10 HANA: 6 × A/Netherlands/602/2009 internal genes H9N2 2P10 RG
P10 HANA: 6 × WF10 internal genes H9N2 2P10:6WF10 RG
Table 1. List of viruses used and discussed in this study, including their abbreviation. Key: WT, wild type; RG, 
reverse genetic constructed; AD, ferret-adapted.
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(Supplementary materials, Figure S1A,B and E). Since the thermal inactivation curves of these H9 viruses showed 
a drop of infectious virus titer  to undetectable levels by 24 hpi (Supplementary materials, Figure S2), the extent 
of the overall viral replication was assessed with the area-under-curve (AUC) analysis using a trapezoid rule. The 
AUCs calculated from 24 to 48 hpi above the detection limit of each virus were compared (Fig. 1F and L). In the 
bronchial (Fig. 1F) and lung cultures (Fig. 1L), 1073 (pink dots) and 2108 (orange dots) showed significantly less 
replication when compared 464419 and its mutant D190E. However, there was no differences between the 464419 
(green dots) with and without the HA-D190E (blue dots) mutation in both the bronchus and the lung.
Avian H9 influenza virus replication in human bronchus and lung organ cultures. In the bron-
chus, Dk/2030 (H9N1) did not infect or replicate in the human bronchial tissue (Fig. 2A), in contrast to the three 
H9N2 avian viruses which infected (Fig. 2B to E) and replicated extensively (Fig. 2E). Nevertheless, H9N1 had a 
lung tropism and replicated equally well when compared to Ck/YU341 and Ck/SSP (Fig. 2J). In contrast, the ex 
vivo cultures of human lung replication competence of Ck/NT449 was significantly lower than other H9 viruses 
(Fig. 2J) though positive antigen was identified (Fig. 2G).
H9 virus replication in human bronchus and lung organ cultures using viruses previously 
demonstrating replication competence in the ferret. In order to determine if the difference in repli-
cation in the bronchus was due to the functional balance between the surface HA and NA, or driven by the virus 
internal gene cassette, we examined the virus tropism using eight strains of H9 virus which had previously shown 
different replication abilities in the ferret: WF10 (an avian H9N2) and its recombinant variants (1WF10, 2WF10, 
2WF10:6M98), a ferret-adapted variant (P10), and it variants (1P10, 2P10, 2P10:6WF10).
The wild type avian H9N2 virus, WF10, infected the human bronchus and lung (Fig. 3A and E). In addition, 
the replacement of NA and the internal genes from H1N1pdm (1WF10) or the replacement of its internal gene 
cassette by H1N1pdm (2WF10), did not statistically alter the replication competence of the virus in human bron-
chus and lung compared to the WF10 (Fig. 3S and T). The more extensive infection observed in 2WF10 infected 
bronchial tissues (Fig. 3C) could be contributed by the balance of the HA and NA in 2WF10 rather than the 
avian-HA and the human-NA of the 1WF10. Strikingly, the internal gene cassette of human H3N2 (Fig. 3D and 
H, 2WF10:6M98) significantly increased the replication competence of the virus in the bronchus (Fig. 3Q and S, 
green dots) when compared to 1WF10 (p = 0.023) and 2WF10 (p = 0.001).
The P10 virus was derived by serial passage of 2WF10:6M98 in ferrets for ten times22, 23. In contrast to the fer-
ret model studied, P10 did not appear to infect or replicate in the human bronchus or the lung (Fig. 3Q and R) and 
immunohistochemistry was negative (Fig. 3I and M). Furthermore, it can be seen that comparing 2WF10:6M98 
(Fig. 3D and H), the ferret adapted P10 has a compromised replication competence in the human bronchus and 
the lung. Moreover, the mutations of P10 in HA and NA acquired would contribute to the less competence pheno-
type, with the fact that 2P10:6WF10 replicated less in the human bronchus (p = 0.14) and in the lung (p = 0.0013) 
when compared to WF10. The mutated surface proteins were less fit to replicate in the human respiratory tract. 
Nevertheless, the internal gene cassette of H1N1pdm in 1P10 and the 2P10 partially rescued their replication 
in the human bronchus (Fig. 3Q, though not reaching statistical significance) and in the human lung (Fig. 3T, 
p < 0.0001 and p = 0.0015, respectively).
Figure 1. The cellular distribution of influenza nucleoprotein in the human bronchus and lung after the 
infection of human H9N2 viruses. The cellular localization of viral antigen (reddish brown) in (A to E) bronchi, 
and (G to K) lung infected with (A and G) A/HK/1073/99 (H9N2), (B and H) A/HK/2108/03 (H9N2), (C and I) 
A/HK/226995/08 (H9N2), (D and J) A/HK/464419/09 (H9N2) viruses and (E and K) A/HK/464419/09-D190E 
(H9N2) at 24hpi were shown. The chart showed the mean and the SD of the AUC values of each virus pooled 
from at least three independent experiments of each virus (F) in the bronchus and (L) in the lung cultures were 
shown. *p < 0.05; **p < 0.01; ***p < 0.005.
www.nature.com/scientificreports/
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Investigation of the role of NA in determining virus replication. To further investigate the corre-
lation between the results in human ex vivo organ culture and animal study, another set of recombinant viruses 
was used. The first H9 virus, rgH9N2, had the HA and NA proteins derived from G1 (H9N2) and its internal 
genes from the A/California/04/2009 (H1N1pdm). The second H9 virus, rgH9N1, had the HA protein derived 
from G1 and the seven other genes from Ca04. In our human ex vivo bronchial and lung organ cultures, both 
viruses showed the ability to replicate over time (Fig. 4A and D), and the rgH9N1, which contained the human 
pandemic-NA, replicated better than rgH9N2 in cells derived from both anatomical sites.
Neuraminidase cleavage of sialoglycans. As there was a difference in replication between the rgH9N1 
and rgH9N2, we investigated what role the NA contributed to the efficient virus budding in the human airways. 
The early H9N2 viruses that infected humans contained a deletion of two amino acids (38 and 39) in the stalk 
region (similar to G1), but also contained similar glycosylation sites with other N2s12. NMR spectroscopy was 
used to assess NA activity of the wild type G1 virus (N2_G1_WT), a reverse genetics virus where the two amino 
acid deletions were restored (N2_G1_38KQ) and a reverse genetics virus with a mutation in P431K which this 
substitution could change the orientation of the NA 430 loop and influence Sia binding24. The main role of viral 
NA is to cleave Sia from the epithelial surface as well as facilitate viral penetration through the sialylated mucus 
layer. While all Sia in humans is primarily N-acetylatyed (Neu5Ac), certain animal species such as pigs have a 
high degree of N-glycolylneuraminic acid (Neu5Gc). High throughput studies by Li and colleagues have demon-
strated that NA activity is more efficient in cleaving 2–3 linked Sia than 2–6 linked Sia, with human viruses also 
efficient in using Neu5Gc as a substrate25. Since certain amino acid changes in NA may lead to a shift in cleav-
age preference from Neu5Ac or Neu5Gc, and thus affect tissue tropism, we produced recombinant viruses that 
contained these signature amino acid changes and examined the NA activity using 3 substrates that contained 
Neu5Ac – 3 sialyllactosamine (3SLN), 6–sialyllactosamine (6-SLN) and Neu5Ac-Gal, and a substrate containing 
Neu5Gc (Neu5Gc-Gal). In all three viruses studied, there was a greater cleavage of the 3-linked Sia than the car-
bon 6-linked Sia (Fig. 5A–C). Supplementary materials, Table S1 shows that only four of the H9N2 viruses had 
this stalk deletion (G1, Y280, 1073 and P10) by amino acid sequences comparison. However this did not appear 
to have any effect on replication in the ex vivo culture of human bronchus or lung tissues by comparing the viral 
replication competence of H9N2 viruses with residues 38–39 deletion in NA stalk, 1073 and P10 with other 
viruses without this deletion such as 2108, 226995 and 464419 (Fig. 1F and L) and did not affect the preference 
between Sia α2–6 glycan or Sia α2–3 glycan cleavages (Fig. 5B), although the overall enzymatic activities were 
slightly higher with the 38KQ insertion in NA.
Discussion
One of the factors determining successful replication of influenza viruses in the human respiratory tract involves 
the interplay between the binding affinity, determined by the host glycan-virus haemagglutinin interaction, and 
the release, determined by the activity and specific of the viral NA. In order to assess whether there was a differ-
ence in the replication abilities of different H9 viruses, we utilized a previously established ex vivo culture system 
Figure 2. The cellular distribution of influenza nucleoprotein and the viral replication extensiveness in the 
human bronchus and lung after the infection with avian H9 viruses. The cellular localization of viral antigen in 
(A to D) bronchi, and (F to I) lung infected with avian (A and F) A/Duck/ST/2030/2001 (H9N1), (B and G) A/
Chicken/HK/NT449/2007 (H9N2), (C and H) A/Chicken/HK/YU341/2008 (H9N2) and (D and I) A/Chicken/
HK/SSP117W/2009 (H9N2) viruses at 24hpi were shown. The chart showed the mean and the SD of the AUC 
values of each virus pooled from at least three independent experiments (E) in the bronchus and (J) in the lung 
cultures were shown. **p < 0.01, ****p < 0.001.
www.nature.com/scientificreports/
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Figure 3. Cellular distribution influenza nucleoprotein in the human bronchus and lung after the infection 
with recombinant and ferret-adapted H9 viruses and the comparison of their replication competence. Cellular 
localization of viral antigen in (A to D) and (I to L) bronchi, and (E to H) and (M to P) lung infected with 
reassortant viruses generated using H9N2 and H1N1pdm (WF10, 1WF10, 2WF10), and using H9N2 and 
H3N2 (2WF10:6M98). (I and M) P10 was the ferret-adapted virus harvested after 10 serial passages in ferrets 
of 2WF10:6M98, with mutation sites at HA1: T189A, HA2: G192R, NA: I28V, PB2: L374I, M1: H110Y, at 
24hpi. Virus replication competence (Q) in the human bronchus and (R) in the human lung were expressed in 
AUC as described in the method. The chart showed the mean and the SD of the AUC pooled from at least four 
independent experiments with the result tables (S and T) showing the statistical comparison between viruses, 
*p < 0.05; **p < 0.01, ***p < 0.005, ****p < 0.001 and ns: p > 0.05.
www.nature.com/scientificreports/
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to investigate the replication ability and tropism of H9 viruses. We found that apart from the P10 virus from fer-
rets, all H9 viruses were able to infect the ex vivo bronchus and lung with greater replication identified in the lung 
than the bronchus. This overall lower replication ability in the bronchus may be due to a loss of balance between 
HA and NA, so that even though virus is being produced, the activity of the NA prevents efficient virus release. 
Indeed, electron microscopy on two of the bronchial samples showed increased numbers of viral particles on the 
surface of the epithelium (Supplementary materials, Figure S3).
In previous publications using ex vivo cultures of the human respiratory tract we have used increase in viral 
titer expressed in TCID50/ml as evidence of successful replication. Our studies have shown that in the absence 
of permissive cells to support viral replication, thermal inactivation leads to the loss of viral infectious titer by 
24 hours (Supplementary materials, Figure S2), Therefore, in this study, we also used AUC between 24–48 hpi to 
express the overall replication competence of the virus. This evaluation correlated well with the positive antigen 
detection in the immunohistochemical stained tissues and the viral titer (Supplementary materials, Figure S1).
The role of the internal genes in determining H9 virus transmission in ferrets has been extensively studied 
by the Perez and other groups22, 26–30. When the H9 had internal genes derived from H3N2 (e.g. 2WF10:6M98), 
there was an increased replication and expanded tissue tropism compared to the wild type, together with a gain in 
transmission by direct contact in ferrets, but aerosol transmission was only possible only after repeated serial pas-
sage in ferrets and the acquisition of further adaptive mutations27. When the H3N2 internal genes were replaced 
with a triple reassortant internal gene (TRIG) cassette, respiratory transmission was possible in ferrets leading 
to clinical disease. If the internal genes were from pH1N1 in mice this also led to documented clinical disease.
Many of the H9N2 viruses have the capacity to bind both Siaα2–3 Gal “avian” and Siaα2–6 Gal “human” 
terminated receptors (found in the human upper and lower respiratory tract)23, however binding was predom-
inantly to Siaα2–6 Gal glycans. Amino acid changes in the HA have been shown to determine the cell tropism 
by altering this α2–3 or α2–6 binding affinity27, and HA-Q226L of avian H9N2 viruses plays a key role on this 
switching23. Sequence analysis of the viruses used in our study (Supplementary materials, Table S1) shows that 
only the Dk/2030, Ck/Yu341, and 464419 (H9N2) maintained the Q226 but were not similar in the distribution of 
viral antigen and replication in the bronchus and lung. Wan and colleagues in 2008 demonstrated that the amino 
acid leucine (L) at 226 was the crucial determinant for direct transmission of avian H9N2 in ferrets with more 
Figure 4. Influence of neuraminidase on H9 virus replication. Replication in the (A–C) bronchus and (D–F) 
lung of reverse genetics H9N2 containing the HA and NA of H9N2/G1 and the internal genes from a pandemic 
H1N1 virus (A/California/04/2009) (rgH9N2), and a comparing virus with only HA of H9N2/G1 and the other 
seven genes from (A/California/04/2009) (rgH9N1). The chart showed the mean and the SEM of the virus titer 
pooled from at least three independent experiments. Asterisks indicated statistical significant increase in viral 
yield at the same time point between the two virus using paired student t-test. *p < 0.05; **p < 0.005.
www.nature.com/scientificreports/
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replication in the upper respiratory tract and multi organ dissemination23. They also showed aerosol transmission 
in ferrets when the H9N2 avian-human reassortant (2WF10:6M98) that caused direct transmission between 
ferrets was serially passaged in ferrets, leading to the acquisition of additional amino acid changes in the HA27. 
Recently, a HA-E190D mutation (the HA 190D is usually found in human seasonal influenza viruses) is observed 
in a human H9N2 virus (A/Hong Kong/464419/2009), but this virus still contained the HA-226Q that maintained 
preferential binding to Siaα2–3 rather than Siaα2–610. The D190E substitution appeared to have no effect on 
replication as assessed by AUC. One of the human isolates had a D190V change (2108) and this appeared to have 
the lowest replication in the lung tissues.
Figure 5. Cleavage of glycans by influenza neuraminidase. Cleavage of different sialylated glycans 
3-sialylolactosamine (3-SLN), 6-sialylolactosamine (6-SLN), Neu5Ac-Galactose (Neu5Ac-Gal) and Neu5Gc-
Gal by (A) H9N2 GI, (B) H9N2 with replacement of the two amino acid stalk deletion and (C) H9N2 with 
mutation of P431K.
www.nature.com/scientificreports/
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In our ex vivo model, the main significant changes impacting on the replication in the human bronchus were 
the change of the internal genes from H1N1 to H3N2 (2WF10 and 2WF10:6M98) (Fig. 3C,D), and the serial pas-
sage of 2WF10:6M98 to P10 (Fig. 3). In contrast to the ferret data, the serially passaged virus (P10) had a limited 
ability to replicate in the bronchus (Fig. 3S), even when the “favourable” H3N2 internal genes were present. This 
finding indicates that the viruses with airborne transmission in the ferret model might not always have efficient 
replication competence in the human bronchus and thus extrapolation of these data to virus transmissibility 
between humans may not be straightforward. The signature amino acid changes seen after serial passage were not 
favourable to replication in the bronchus or lung but that these could be improved by replacing the N2 (ferret) 
with N1 (human) in the lung (Fig. 3M,N,S and T).
Previously we did not know whether the lack of human-to-human transmission of H9N2 was due to poor 
binding because of HA difference, replication competence because of the internal gene cassette or virus release 
due to different N1 or N2 proteins. As some ex vivo infections had positive IHC but low virus replication, this 
suggests that a low virus release may be a more likely scenario. We have demonstrated that replication in the 
bronchus and the lung differs between the rgH9N1 and rgH9N2 (Fig. 4), and that in the serially passaged virus 
1P10 has greater replication than P10 (Fig. 3T). Thus it is possible that one of the main reasons for the poor 
transmission between humans of H9N2 would be the N2 is not well-adapted or “fit” for the human airway. It has 
previously been reported that there is a difference in cleavage of substrates between the N1 and N2 with the latter 
showing a lower substrate specificity than N131. Our NMR and N2 mutation assay confirmed that 2–6 linked Sia 
(which comprised most of the mucin of the upper respiratory tract)32 was less efficiently cleaved than 2–3 linked 
Sia (Fig. 5A–C).
The N2 of H9N2 shows some degree of amino acid variation between strains. The early H9N2 viruses that 
infected humans contained a deletion of two amino acids (38 and 39) in the stalk region (similar to G1), but also 
contained similar glycosylation sites with other N2s12. In contrast, Y280 contained a deletion of three amino acids 
(position 63–65), however many other H9N2 isolates (including those that were isolated from the 2008 and 2009 
human H9N2 infections) have no deletions33. This stalk deletion has been associated with an adaptation of viruses 
from waterfowl to terrestrial poultry, and was present in the emergence of the H7N9 virus that infected humans 
in 201334. This deletion increased replication in mice and chickens with increased severity of primary disease35, 
though it was not the case in the ex vivo infection of human respiratory tissue by 1073 and P10 in this study. 
Furthermore, a recent study on the amino acid changes in NA resulting in airborne transmission in chickens36 
showed that none of the amino acid changes in the airborne transmissible and non-airborne transmissible virus 
involved the stalk. Similar to a previous publication37, the mutation of the P431K increased cleavage of Neu5Gc 
(Fig. 5C).
Conclusions
An important aspect in the study of influenza virus biology and ecology has been whether the airborne trans-
mission of an influenza virus in ferrets can be directly and universally applied to imply transmissibility between 
humans, and whether the sites of replication of these reassortant H9N2 viruses in ferrets may comparable when 
the human respiratory tract is used. This consideration is important, as replication of H9N2 in the ferret has been 
included as a risk assessment of H9N2 viruses19.
The risk assessment models published previously placed emphasis on replication in ferrets, pigs and the role 
of HA226 but we found that this was not always a reliable predictor of an increased replication competence in ex 
vivo cultures of the human respiratory tract. Since N2 is a relatively weak NA and the bronchial environment has 
abundant 2–6 linked glycans, we now propose that the action of the NA as well as ex vivo cultures of the human 
bronchus and lung should be considered in conducting future risk assessments of H9N2 viruses.
Our ex vivo studies have shown the human adult bronchus and lung is readily susceptible to infection by 
H9N1 and H9N2 viruses that are commonly found in poultry in the region, with a greater degree of replica-
tion identified in the lungs than bronchi. We found that amino acid changes favouring replication and airborne 
transmission identified in the ferret model did not always lead to a better replication in the human system. Ex 
vivo cultures of the human lung and bronchus provides a useful system for investigating avian-to-human and 
human-to-human transmission as the two important questions regarding the potential zoonotic and pandemic 
threat posed by H9N2 viruses.
Materials and Methods
Virus culture. Four wild type strains of avian H9 influenza virus and four wild type strains of human 
H9N2 virus were employed in this study and detailed in Table 1. The signature amino acid changes are listed 
in Supplementary materials, Table S1. A reverse genetics virus 464419-D190E re-constructed with A/Hong 
Kong/464419/2009 (H9N2) backbone was prepared as described38. All viruses were plaque purified and passaged 
three times in Madin-Darby Canine Kidney (MDCK) cells and their identity was confirmed by sequencing.
In order to study whether H9 viruses that replicated in the ferret model would replicate in our ex vivo system, 
a panel of eight viruses previously generated using plasmid based reverse genetics and tested in ferret models 
were used. Briefly, these viruses include the parent virus A/guinea fowl/Hong Kong/WF10/1999 (H9N2, WF10), 
and three H9N2 avian-human reassortant viruses: 1WF10, which contains the HA gene of WF10 and the NA and 
the six internal genes of A/Netherlands/602/2009 (H1N1pdm); 2WF10, which contains the HA and NA genes of 
WF10 and the six internal genes of H1N1pdm, and 2WF10:6M98 which contains the HA and NA genes of WF10 
and the six internal genes of A/Memphis/14/1998 (H3N2, M98).
The second set of viruses was based on A/ferret/Maryland/P10_UMD/2008 (P10) (H9N2), which was the 
result of 10 serial passages in ferrets of the 2WF10:6M98 (avian-human H9N2:H3N2)22. Compared with the 
parent virus, P10 possessed mutations at surface proteins, HA1-T189A, HA2-G192R and NA-I28V, internal pro-
teins, PB2-L374I and M1-H110Y. In addition, three reassortant viruses with the surface protein(s) of P10 were 
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generated. 1P10 contains the HA from P10 and the other even genes from H1N1pdm, whereas 2P10 contains the 
HA and NA genes from P10 and the six internal genes from H1N1pdm. Lastly, the 2P10:6WF10 which encodes 
the HA and NA genes from P10 and the six internal genes from WF10 was produced (Table 1).
The role of neuraminidase of H9N2/G1 in relation to human tissue tropism was studied by using two recom-
binant H9N2 viruses: a H9N2 (rH9N2) containing the HA and NA of G1 and the internal genes from a pandemic 
H1N1 virus A/California/04/2009 (H1N1pdm), and a comparable virus (rH9N1) with only HA of G1 and the 
other seven genes from A/California/04/2009.
Ex vivo organ culture and infection. Fresh biopsies of human bronchi and lung from human lung samples 
were collected from patients undergoing surgical resection of bronchus and lung tissues and infected as previ-
ously described39–41. Informed consent has been obtained from all subjects and only normal tissues were used 
for infection. This study was approved by the Institutional Review Board of the University of Hong Kong and 
Hospital Authority Hong Kong West Cluster (UW 14–119) and all methods involving human tissues were per-
formed in accordance with relevant guidelines and regulations. Samples for ex vivo cultures of human bronchus 
and lung were provided by at least three independent donors. Bronchial and lung tissues were infected with the 
H9 viruses with a viral titer of 106 50% tissue culture infectious doses (TCID50)/ml, similar to that used previ-
ously39–41, for 1 h at 37 °C and washed with 5 ml of PBS for three times to remove unbound virus. Mock-inoculated 
tissues served as negative controls. Viral replication was determined by examining the viral titer from the super-
natant cultures collected at 1, 24 and 48 hours post infection (hpi).
Virus titration assay and area under curve (AUC). Viral titration assay in MDCK cells was performed 
as described previously and expressed as TCID50/ml39–41. Serial dilutions of culture supernatants from infected 
cultures were titrated in parallel onto confluent 96-well tissue culture plate of MDCK cells plates in quadrupli-
cate and cytopathic effect (CPE) was monitored daily. The end point of viral dilution leading to CPE in 50% of 
inoculated wells was estimated using the Karber method. The kinetics of thermal inactivation of these H9 viruses 
over time were also performed at 37 °C by adding 1 ml of virus into 24-well plates with different virus titres (104 
and 103 TCID50/ml) in the absence of permissive cells. 130 μl of supernatant was collected at 1, 24, and 48 h post 
incubation to measure viral titer. The replication curves were plotted using the log10-transformed viral titers 
among different viruses at different time points post-infection (Supplementary materials, Figure S1). Since the 
thermal inactivation curves of these H9 viruses showed virus infectivity decreasing to undetectable levels by 
24 hpi (Supplementary materials, Figure S2), the extent of the overall viral replication was assessed with the 
area-under-curve (AUC) analysis using a trapezoid rule42.
Nuclear magnetic resonance (NMR) spectroscopy. Enzymatic activity of viral NA against 
3′-Sialyl-N-acetyllactosamine (3′SLN), 6′-Sialyl-N-acetyllactosamine (6′SLN), N-Acetylneuraminyl-galactose 
(Neu5Ac-Gal) and N-Glycolylneuraminicyl-galactose (Neu5Gc-Gal) was detected with NMR spectroscopy as 
detailed previously43. All NMR experiments were performed on a Varian 750 MHz spectrometer. H9N2 viruses 
were purified by ultracentrifugation and fixed in 0.2% paraformaldehyde for 16 hours. 1H NMR spectra were 
obtained every 5 minutes during the 1 h incubation of the virus with glycan substrates at 37 °C. Cleavage of sialic 
acid (Sia) moieties of the substrates was calculated by the change of chemical shift of the methyl protons within 
the N-acetamido group.
Immunohistochemistry. Organ cultures of the respiratory tissue were fixed and paraffin embedded for 
sectioning and the detection of influenza antigen as described previously44. Sections were incubated with HB65 
antibody against the nucleoprotein protein for 1 h at room temperature, followed by the addition of biotinylated 
rabbit anti-mouse antibody. Sections were developed with a Vector NovaRed substrate kit (SK-4800).
Statistical analysis. Experiments were performed independently at least three times, with different donors. 
The extent of the overall viral replication of each virus in the experiment time course was represented by the AUC 
analysis using a trapezoid rule as described42. Results shown in the figures are the calculated mean AUC and 
standard deviation (SD) from such replicate experiments. The AUCs were compared among viruses by one-way 
ANOVA followed by Bonferroni multiple-comparisons test. Differences were considered significant at a p < 0.05. 
The statistical analysis was performed using Graph-Pad Prism 6.0 version for Mac.
Biosafety and biosecurity. All the experiments that involved the use of the recombinant viruses were con-
ducted in a biosafety level 3 facility at the University of Hong Kong and were risk assessed and approved by the 
both the Departmental Safety Committee of the School of Public Health, LKS Faculty of Medicine, as well as the 
Biosafety Committee of the University of Hong Kong. In addition, this study has passed both the biological and 
biosecurity risk assessment of the University risk assessment for work with infectious agents.
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